Atricure Stock Performance
| ATRC Stock | USD 29.26 0.49 1.65% |
The firm shows a Beta (market volatility) of 0.91, which signifies possible diversification benefits within a given portfolio. AtriCure returns are very sensitive to returns on the market. As the market goes up or down, AtriCure is expected to follow. At this point, AtriCure has a negative expected return of -0.0946%. Please make sure to confirm AtriCure's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if AtriCure performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days AtriCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, AtriCure is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (1.65) | Five Day Return (4.75) | Year To Date Return (3.75) | Ten Year Return 19.19 | All Time Return 107.81 |
1 | AtriCure Q1 Earnings Taking a Look at Key Metrics Versus Estimates | 04/29/2025 |
2 | AtriCure Given New 44.00 Price Target at Needham Company LLC | 05/01/2025 |
3 | Disposition of 585 shares by Justin Noznesky of AtriCure subject to Rule 16b-3 | 05/16/2025 |
4 | Acquisition by Groves Regina E of 5401 shares of AtriCure subject to Rule 16b-3 | 05/19/2025 |
5 | AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference ATRC ... | 05/23/2025 |
6 | Investors push AtriCure 3.9 percent lower this week, companys increasing losses might be to blame | 05/27/2025 |
7 | Disposition of 2500 shares by Vinayak Doraiswamy of AtriCure at 33.44 subject to Rule 16b-3 | 05/28/2025 |
8 | Acquisition by Privitera Salvatore of 22586 shares of AtriCure subject to Rule 16b-3 | 06/05/2025 |
9 | AtriCure, Inc. Stock Analysis Unveiling a 56 percent Potential Upside with Strong Buy Consensus - DirectorsTalk Interviews | 06/24/2025 |
10 | Acquisition by Dahlquist Karl S. of 19359 shares of AtriCure subject to Rule 16b-3 | 06/25/2025 |
11 | Acquisition by Dahlquist Karl S. of 822 shares of AtriCure at 25.84 subject to Rule 16b-3 | 06/30/2025 |
12 | AtriCure to Announce Second Quarter 2025 Financial Results | 07/08/2025 |
13 | AtriCure Inc Completes Enrollment for LeAAPS Clinical Trial ATRC stock news | 07/15/2025 |
14 | Abbott Q2 Earnings and Revenues Top Estimates | 07/17/2025 |
| Begin Period Cash Flow | 84.3 M | |
| Total Cashflows From Investing Activities | 30.2 M |
AtriCure Relative Risk vs. Return Landscape
If you would invest 3,174 in AtriCure on April 20, 2025 and sell it today you would lose (248.00) from holding AtriCure or give up 7.81% of portfolio value over 90 days. AtriCure is currently does not generate positive expected returns and assumes 2.6734% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than AtriCure, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AtriCure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AtriCure, and traders can use it to determine the average amount a AtriCure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0354
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATRC |
Estimated Market Risk
| 2.67 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AtriCure is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AtriCure by adding AtriCure to a well-diversified portfolio.
AtriCure Fundamentals Growth
AtriCure Stock prices reflect investors' perceptions of the future prospects and financial health of AtriCure, and AtriCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AtriCure Stock performance.
| Return On Equity | -0.0838 | ||||
| Return On Asset | -0.037 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 1.37 B | ||||
| Shares Outstanding | 49.5 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 3.80 X | ||||
| Price To Sales | 3.02 X | ||||
| Revenue | 465.31 M | ||||
| Gross Profit | 358.88 M | ||||
| EBITDA | (18.53 M) | ||||
| Net Income | (44.7 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 76.53 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | 9.19 X | ||||
| Cash Flow From Operations | 12.2 M | ||||
| Earnings Per Share | (0.81) X | ||||
| Market Capitalization | 1.45 B | ||||
| Total Asset | 609.33 M | ||||
| Retained Earnings | (401.75 M) | ||||
| Working Capital | 194.4 M | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
About AtriCure Performance
By analyzing AtriCure's fundamental ratios, stakeholders can gain valuable insights into AtriCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AtriCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AtriCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 233.46 | 133.18 | |
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.07) | (0.08) | |
| Return On Equity | (0.10) | (0.10) |
Things to note about AtriCure performance evaluation
Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AtriCure generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 358.88 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: What To Expect From AngioDynamics Inc Q4 2025 Earnings |
- Analyzing AtriCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AtriCure's stock is overvalued or undervalued compared to its peers.
- Examining AtriCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AtriCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AtriCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AtriCure's stock. These opinions can provide insight into AtriCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |